Navigation Links
Selenium-protein deficiency raises prostate cancer risk

Selenium, an essential dietary mineral that can act as an antioxidant when incorporated into proteins, has been shown in many studies to reduce the incidence of cancers -- notably lung, colorectal and prostate.

"The problem is, nobody seems to know how the mechanism works, and that's not trivial," said Alan Diamond, professor of human nutrition at the University of Illinois at Chicago and principal investigator in an ongoing multidisciplinary study set up at UIC to help answer that question.

"Knowing how it works allows you to maximize-out its benefits," he said.

Diamond and his colleagues report in the May 23 issue of the Proceedings of the National Academy of Sciences on research findings using specially bred transgenic mice that suggest it is the level of selenium-containing proteins in the body that is instrumental in preventing cancer, and that dietary selenium plays a role in stimulating the body's level of these selenoproteins.

Two genetically manipulated mice were mated. One was prone to developing prostate cancer. The other had lower levels of selenoproteins. Approximately 50 offspring that carried both traits were studied to see if the reduced levels of selenoproteins accelerated cancer development. As the researchers suspected, it did.

"It's a hardcore link in an animal model system of selenium-containing proteins to prostate cancer and, by extrapolation, the mechanism by which selenium prevents cancer," said Diamond.

Further research is underway to corroborate the stimulating effect of dietary selenium in enhancing levels of protective selenoproteins. Diamond added that much work remains to be done to discover exactly how selenoproteins play their protective role, and in whom.

At least 25 different selenoproteins have been found in the human body. But what role each plays is not known, nor is it known if certain persons are genetically more -- or less -- receptive to the benefits of these proteins, o r to a selenium supplement, Diamond said.

The effectiveness of selenium may be due to its effects on a single selenoprotein, or combinations of several members of this class. One selenoprotein in particular, glutathione peroxidase, is of special interest to Diamond and his associates. They plan to run new tests using new mice genetically modified to reduce levels of just this one selenoprotein.

"If reductions result in accelerated prostate cancer, then we have our player," he said.

Other UIC faculty participating in the study include Veda Diwadkar-Navsariwala, post-doctoral researcher in human nutrition; Gain Prins, professor of urology; Steven Swanson, associate professor of medicinal chemistry and pharmacognosy; Lynn Birch, research specialist in urology; Vera Ray, clinical assistant professor of pathology; Sadam Hedayat, distinguished professor of statistics; and Daniel Lantvit, research specialist in pharmaceutical sciences.


'"/>

Source:University of Illinois at Chicago


Related biology news :

1. Gene for immune deficiency syndromes found
2. Study finds that nutritionally enhanced rice reduces iron deficiency
3. Poor athletic performance linked to vitamin deficiency
4. Vitamin D deficiency widespread during pregnancy
5. Mutation in clams protects against paralytic shellfish poisoning but raises human health risk
6. Ethiopian development raises birth rate
7. Jefferson scientists find high glucose before surgery raises risk of dangerous complications
8. Childhood obesity among Quebec Cree raises concerns
9. Mitochondrial DNA mutations play significant role in prostate cancer
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. Test for early detection of prostate cancer shows promise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology: